BANF1P2

Across TCGA pan-cancer cohorts, BANF1P2 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated BANF1P2 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher BANF1P2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated BANF1P2 expression acts as an unfavorable survival marker, although some lineages such as KIRC and LIHC show a favorable association.

COAD, ACC, and KIRP are the cancer types where BANF1P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	All	0.480	0.737	<.001	125	view →
ACC	DFS	Median	All	0.247	0.645	<.001	88	view →
KIRP	OS	Quartile	III,IV	0.258	0.703	.004	23	view →
KIRC	DFS	Median	II,III,IV	0.825	0.676	.005	18	view →
LIHC	OS	Median	All	0.742	0.633	.010	11	view →
DLBC	DFS	Median	All	0.643	1.000	.021	9	view →
CHOL	OS	Median	IV	0.208	0.948	.010	8	view →
SARC	OS	Quartile	All	0.664	0.887	.014	8	view →
BLCA	OS	Median	All	0.755	0.622	.033	6	view →
HNSC	OS	Quartile	III,IV	0.530	0.352	.019	6	view →
UCS	OS	Median	IV	0.248	0.673	.033	6	view →
PRAD	DFS	Tertile	All	0.719	0.805	.031	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

BANF1P2–COAD (OS)

Open the COAD breakdown →